3 No-Brainer Stocks to Buy in June
You're probably familiar with the old adage, "April showers bring May flowers." And you probably know the punchline to the question, "What do May flowers bring?" (The answer: Pilgrims.)
But what does June bring? Three Motley Fool contributors think the new month should usher in great investing opportunities. Here's why they picked (NYSE: ABBV), AstraZeneca (NASDAQ: AZN), and Vertex Pharmaceuticals (NASDAQ: VRTX) as no-brainer stocks to buy in June.
Keith Speights (AbbVie): Some stocks only appeal to income investors. Others are only attractive to value investors. In many cases, stocks in either category offer dismal growth prospects. AbbVie is an exception that covers all of the bases.
Source Fool.com
AbbVie Inc. Aktie
226,90 €
1,25 %
Klare Kaufstimmung: AbbVie Inc. hat 47 Buy-Einschätzungen und keine Sell-Einschätzung.
Ein Kursziel von 231 € für AbbVie Inc. signalisiert ein leicht positives Potenzial gegenüber dem aktuellen Kurs von 226.9 €.
